July 31, 2013
Novartis Pres. Yoshiyasu Ninomiya (left) Novartis Pharma’s third-party investigation discovered that its former employee had access to cardiovascular data used in clinical trials on Diovan (valsartan) before they were locked, according to an investigative report released by the company on...read more